YERXA BENJAMIN R — SEC insider filings
SEC reporting owner CIK 1145910. 12 insider filings on record with FilingPulse; latest filed 2026-10-27.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2022-03-04 to 2026-10-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 17,813 shares, $20,069 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 48,088 shares, $178,550 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 25,520 shares @ $3.53 ($90,129) in Opus Genetics, Inc., filed 2026-10-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | President, Director | 7 | 1 leg · 10,000 sh · $9,834 | 4 legs · 48,088 sh · $178,550 | 3 |
| Clearside Biomedical, Inc. (CLSD) | Director | 5 | 1 leg · 7,813 sh · $10,235 | — | 4 |
Insider filings — YERXA BENJAMIN R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,669 @ $3.55 · Sale (S): 25,520 @ $3.53 | EDGAR |
| 2026-07-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,429 @ $2.97 | EDGAR |
| 2026-04-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,470 @ $5.24 | EDGAR |
| 2026-01-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2025-10-24 | 4 | Opus Genetics, Inc. (IRD) | Tax withholding (F): 23,795 @ $1.95 | EDGAR |
| 2024-11-25 | 4 | Opus Genetics, Inc. (IRD) | Purchase (P): 10,000 @ $0.98 | EDGAR |
| 2024-11-12 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 332,800 @ $0 | EDGAR |
| 2024-06-21 | 4 | Clearside Biomedical, Inc. (CLSD) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | Clearside Biomedical, Inc. (CLSD) | Purchase (P): 7,813 @ $1.31 | EDGAR |
| 2023-06-23 | 4 | Clearside Biomedical, Inc. (CLSD) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Clearside Biomedical, Inc. (CLSD) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | Clearside Biomedical, Inc. (CLSD) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-11-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1145910 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs